Second-generation antipsychotics in primary and secondary delusional parasitosis: Outcome and efficacy

Journal of Clinical Psychopharmacology

Volumn 28, Issue 5, 2008, Pages 500-508

  Freudenmann, Roland W ^a   Lepping, Peter ^b  

^a UNIVERSITY OF ULM   (Germany)

^b Wrexham Academic Unit   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANTIPARKINSON AGENT; ANXIOLYTIC AGENT; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CAPTOPRIL; CARBAMAZEPINE; CARBIDOPA PLUS LEVODOPA; CITALOPRAM; DIAZEPAM; DONEPEZIL; FLUVOXAMINE; FUROSEMIDE; IMIPRAMINE; LEVOCETIRIZINE; LORATADINE; MOCLOBEMIDE; OLANZAPINE; PAROXETINE; PIMOZIDE; QUETIAPINE; RISPERIDONE; SERTINDOLE; SERTRALINE; STEROID; UNINDEXED DRUG; VENLAFAXINE; ZIPRASIDONE; BENZODIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT;

ACUTE DISEASE; ADD ON THERAPY; ARTICLE; CASE STUDY; DELUSIONAL DISORDER; DELUSIONAL PARASITOSIS; DEPRESSION; DISEASE DURATION; DRUG EFFICACY; DRUG WITHDRAWAL; DYSTONIA; EXTRAPYRAMIDAL SYMPTOM; GENDER; HUMAN; HYPONATREMIA; ONSET AGE; PRIORITY JOURNAL; REMISSION; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; ADOLESCENT; ADULT; AGED; DELUSION; DOSE RESPONSE; FEMALE; INFESTATION; MALE; METHODOLOGY; MIDDLE AGED; PSYCHOLOGICAL ASPECT; PUBLISHING; TIME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; DELUSIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; ECTOPARASITIC INFESTATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PUBLICATION BIAS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; RISPERIDONE; TIME FACTORS; TREATMENT OUTCOME;

EID: 58149133960     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e318185e774     Document Type: Article

References (39)

1. Thibierge G. Les acarophobes. Rev Gen Clin Thër. 1894;32:373-376.
2. Trabert W. 100 Jahre Dermatozoenwahn [100 years of delusional parasitosis]. Med Welt. 1997;48:33-37.
3. Freudenmann RW. Der "Dermatozoenwahn." Eine aktuelle Ubersicht. [Delusions of parasitosis: an up-to-date review]. Fortschr Neurol Psychiatr. 2002;70:531-541.
4. Trabert W. 100 years of delusional parasitosis. Meta-analysis of 1,223 case reports. Psychopathology. 1995;28:238-246.
5. Lyell A. Delusions of parasitosis (The Michelson lecture). Br J Dermatol. 1983;108:485-499.
6. Skott A. Delusions of Infestation. Dermatozoenwahn-Ekbom's Syndrome. Report From the Psychiatric Research Center. Goteborg, St. Jorgen Hospital, university of Goteborg, Sweden; 1978.
7. Trabert W. Epidemiologie des dermatozoenwahns [Epidemiology of delusional ectoparasitic infestation]. Nervenarzt. 1991;62:165-169.
8. Lepping P, Russell I, Freudenmann RW. Antipsychotic treatment of delusional parasitosis: systematic review. Br J Psychiatry. 2007;191:198-205.
9. Berrios GE. Delusional parasitosis and physical disease. Compr Psychiatry. 1985;26:395-403.
10. Lepping P, Freudenmann RW. Delusional parasitosis: a new pathway for diagnosis and treatment. Clin Exp Dermatol. 2008;33:113-117.
11. Bourgeois M, Rager P, Peyre F, et al. Frequence et aspects du syndrome d'Ekbom enquête auprès des dermatologues francais (A propos de 150 cas). Ann Med Psychol (Paris). 1986;144:659-668.
12. Szepietowski JC, Salomon J, Hrehorow E, et al. Delusional parasitosis in dermatological practice. J Eur Acad Dermatol Venereol. 2007;21:462-465.
13. Trabert W. Shared psychotic disorder in delusional parasitosis. Psychopathology 1999;32:30-34.
14. Musalek M, Kutzer E. The frequency of shared delusions in delusions of infestation. Eur Arch PsychiatryNeurol Sci. 1990;239:263-266.
15. Ryan CJ, de Moore G, Patfield M. Becoming none but tradesmen: lies, deception and psychotic patients. J Med Ethics. 1995;21:72-76.
16. Munro A. Delusional Hypochondriasis. A Description of Monosympto- matic Hypochondriacal Psychosis (MHP). Toronto: Clarke Institute of Psychiatry Monograph Series, Department of Psychiatry, University of Toronto; 1982.
17. Freudenmann RW, Schönfeldt-Lecuona C. Delusional parasitosis: treatment with atypical antipsychotics (letter). Ann Acad Med Singap. 2005;34:141-142.
18. Gould WM, Gragg TM. Delusions of parasitosis. An approach to the problem. Arch Dermatol. 1976;112:1745-1748.
19. Reilly T, Batchelor D. The presentation and treatment of delusional parasitosis: a dermatological perspective. Int Clin Psychopharmacol. 1986;1:340-353.
20. Hamann K, Avnstorp C. Delusions of infestation treated by pimozide: a double-blind crossover clinical study. Acta Derm Venereol. 1982;62:55-58.
21. Ungvari G, Vladar K. Pimozide treatment for delusion of infestation. Act Nerv Super (Praha). 1986;28:103-107.
22. Riding J, Munro A. Pimozide in the treatment of monosymptomatic hypochondriacal psychosis. Acta Psychiatr Scand. 1975;52:23-30.
23. Munro A. Monosymptomatic hypochondriacal psychosis manifesting as delusions of parasitosis. A description of four cases successfully treated with pimozide. Arch Dermatol. 1978;114:940-943.
24. Munro A. Delusional parasitosis: a form of monosymptomatic hypochondriacal psychosis. Semin Dermatol. 1983;2:197-202.
25. Elmer KB, George RM, Peterson K. Therapeutic update: use of risperidone for the treatment of monosymptomatic hypochondriacal psychosis. JAm Acad Dermatol. 2000;43:683-686.
26. Lorenzo CR, Koo J. Pimozide in dermatologic practice: a comprehensive review. Am J Clin Dermatol. 2004;5:339-349.
27. Musalek M, Bach M, Gerstberger K, et al. Zur Pharmakotherapie des Dermatozoenwahns. Die Bedeutung der Differentialdiagnose fUr die psychopharmakologische Behandlung von Dermatozoenwahnkranken [Drug therapy of delusional parasitosis. The importance of differential diagnosis for psychopharmacologic treatment of patients with delusional parasitosis]. Wien Med Wochenschr. 1989;139:297-302.
28. Trabert W. Der Dermatozoenwahn. Untersuchungen zur Haufigkeit, Klassifikation und Prognose [Delusional Parasitosis. Studies on Frequency, Classification and Prognosis]. Habilitationsschrift. Homburg/ Saar: Universitat des Saarlandes; 1993.
29. Fawcett RG. Olanzapine for the treatment of monosymptomatic hypochondriacal psychosis. J Clin Psychiatry. 2002;63:169.
30. Mercan S, Altunay IK, Taskintuna N, et al. Atypical antipsychotic drugs in the treatment of delusional parasitosis. Int J Psychiatry Med. 2007;37:29-37.
31. Mercan S, Ögütcen Ö, Altunay IK, et al. Folie à famille ve Delüzyonel Parazitoz: Olgu Sunumu ve Literaturun Gözden Gecirilmesi. Klin Psikofarmakol Bül. 2005;15:71-78.
32. Freudenmann RW, Schönfeldt-Lecuona C, Lepping P. Primary delusional parasitosis treated with olanzapine. Int Psychogeriatr. 2007;19: 1161-1168.
33. Musalek M. Der Dermatozoenwahn. Stuttgart. New York: Thieme; 1991.
34. Mester H. Induzierter "Dermatozoenwahn" [Induced "acarophobia"]. Psychiatr Clin. 1975;8:339-348.
35. Bhatia MS, Jagawat T, Choudhary S. Delusional parasitosis: a clinical profile. Int J Psychiatry Med. 2000;30:83-91.
36. Lieberman JA, Stroup TS, McEvoy JP, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005;353:1209-1223.
37. Jones PB, Barnes TR, Davies L, et al. Randomized controlled trial of the effect on quality of life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). Arch Gen Psychiatry. 2006; 63:1079-1087.
38. Frithz A. Delusions of infestation: treatment by depot injections of neuroleptics. Clin Exp Dermatol. 1979;4:485-488.
39. Ungvari G. Behandlung des Dermatozoenwahns durch Neuroleptika [Treatment of a dermatozoon delusion with neuroleptics]. Psychiatr Prax. 1984;11:116-119.